These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19926070)

  • 1. [Management of acromegaly in pregnant woman].
    Ben Salem Hachmi L; Kammoun I; Bouzid C; Smida H; Nagi S; Turki Z; Ben Slama C
    Ann Endocrinol (Paris); 2010 Feb; 71(1):60-3. PubMed ID: 19926070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy in women after successful acromegaly treatment, including surgical removal of pituitary adenoma and postoperative therapy using lanreotide acetate.
    Teltayev D; Akshulakov S; Ryskeldiev N; Mustafin K; Vyacheslav L
    Gynecol Endocrinol; 2017; 33(sup1):50-51. PubMed ID: 29264984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acromegaly and pregnancy: report of six new cases].
    Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy associated with recurrent acromegaly: a case report.
    Edo AE; Eregie A
    West Afr J Med; 2010; 29(2):120-2. PubMed ID: 20544639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pregnancy in active acromegaly].
    Sahli R; Christ E
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2328-31. PubMed ID: 18958828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of acromegaly in pregnancy: concomitant transsphenoidal adenomectomy and cesarean section.
    Guven S; Durukan T; Berker M; Basaran A; Saygan-Karamursel B; Palaoglu S
    J Matern Fetal Neonatal Med; 2006 Jan; 19(1):69-71. PubMed ID: 16492596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma.
    Cannavò S; Squadrito S; Curtò L; Almoto B; Trimarchi F
    Horm Metab Res; 2001 Oct; 33(10):618-24. PubMed ID: 11607883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes associated with asymptomatic acromegaly successfully treated with surgery after pregnancy: a case report.
    Iwai H; Ito H; Ri S; Harada T; Hirota N; Yamauchi T; Miyatake T; Ohno Y; Aoki N
    Endocr J; 2005 Aug; 52(4):413-20. PubMed ID: 16127208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term primary medical therapy with somatostatin analogs in acromegaly.
    Su DH; Liao KM; Chen HW; Chang TC
    J Formos Med Assoc; 2006 Aug; 105(8):664-9. PubMed ID: 16935768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of endocrine disease: GH excess: diagnosis and medical therapy.
    Andersen M
    Eur J Endocrinol; 2014 Jan; 170(1):R31-41. PubMed ID: 24144967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of disease activity and tumor size after introduction of pegvisomant in a lanreotide-resistant acromegalic patient.
    Fendri S; Karaca P; Tiev E; Buchfelder M; Lalau JD
    Ann Endocrinol (Paris); 2013 Feb; 74(1):49-52. PubMed ID: 23337021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa.
    Maiza JC; Vezzosi D; Matta M; Donadille F; Loubes-Lacroix F; Cournot M; Bennet A; Caron P
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):282-9. PubMed ID: 17524029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic acromegaly due to a GH-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature.
    Ramírez C; Hernández-Ramirez LC; Espinosa-de-los-Monteros AL; Franco JM; Guinto G; Mercado M
    BMC Res Notes; 2013 Oct; 6():411. PubMed ID: 24119925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
    Karavitaki N; Turner HE; Adams CB; Cudlip S; Byrne JV; Fazal-Sanderson V; Rowlers S; Trainer PJ; Wass JA
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):970-5. PubMed ID: 18031313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal.
    Auriemma RS; Galdiero M; Grasso LF; Vitale P; Cozzolino A; Lombardi G; Colao A; Pivonello R
    Eur J Endocrinol; 2010 May; 162(5):993-9. PubMed ID: 20156970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.